Drug-coated balloon versus drug-eluting stent for treating de novo coronary lesions in large vessels: a  meta-analysis of clinical trials.

CONCLUSION: This meta-analysis indicated that DCB might be non-inferior to DES as evidenced by quantitative coronary angiography (QCA) assessed at 6-9 months after percutaneous coronary intervention in patients presenting with coronary artery disease. PMID: 32468141 [PubMed - as supplied by publisher]
Source: Herz - Category: Cardiology Tags: Herz Source Type: research